Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin: Toxicity, dosimetry, and therapeutic response

Anuradha Soundararajan, Ande Bao, William T. Phillips, Linda M. McManus, Beth A. Goins

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin: Toxicity, dosimetry, and therapeutic response'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science